Skip to main content
. 2021 Jul 30;11:678343. doi: 10.3389/fonc.2021.678343

Figure 9.

Figure 9

HITC and DDI behave as cancer stem cell inhibitors. Non-adherent MCF7 cells were treated using different drug concentrations of HITC, DDI and IR780 (1, 50, 100, 500, 1,000 nM) for five days and then mammospheres were counted. Data are expressed as fold increase Vs control. Statistical analysis was conducted using one-way ANOVA.